Factitious biochemical measurements resulting from hematologic conditions

American Journal of Clinical Pathology

Volumn 131, Issue 2, 2009, Pages 195-204

  Dalal, Bakul I ^a   Brigden, Malcolm L ^b  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

^b SASKATCHEWAN CANCER AGENCY   (Canada)

Author keywords

Artifact; Factitious; Hyperkalemia; Myeloma; Paraprotein

Indexed keywords

ALBUMIN; ANTICOAGULANT AGENT; BILIRUBIN; BROMOCRESOL GREEN; C REACTIVE PROTEIN; CALCIUM; CHLORIDE; COBALAMIN; CREATININE; DITHIOTHREITOL; FERRITIN; FLUORIDE; FOLIC ACID; GLUCOSE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HEMOGLOBIN A1C; HEXOKINASE; HIGH DENSITY LIPOPROTEIN; IMMUNOGLOBULIN; OXALIC ACID; PARAPROTEIN; PHOSPHATE; PHTHALALDEHYDE; POTASSIUM; SODIUM; THYROXINE; UREA; URIC ACID;

ALBUMIN BLOOD LEVEL; ANALYTIC METHOD; ANALYTICAL EQUIPMENT; ANALYTICAL ERROR; ANALYZER; ARTIFACT; ARTIFACT REDUCTION; ASSAY; BLEEDING; BLOOD GAS ANALYSIS; BLOOD TRANSFUSION; CLINICAL LABORATORY; CONTINUING EDUCATION; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; ENZYME BLOOD LEVEL; ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE; ERYTHROCYTE MEMBRANE; FACTITIOUS DISEASE; FERRITIN BLOOD LEVEL; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEMATOLOGIC DISEASE; HEMOLYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERBILIRUBINEMIA; HYPERCALCEMIA; HYPERIMMUNOGLOBULINEMIA; HYPERKALEMIA; HYPERPHOSPHATEMIA; HYPOALBUMINEMIA; HYPOGLYCEMIA; HYPOKALEMIA; HYPOLIPEMIA; HYPONATREMIA; HYPOPHOSPHATEMIA; HYPOURICEMIA; HYPOXEMIA; LABORATORY TEST; MEDICAL INSTRUMENTATION; MYELOMA; NEPHELOMETRY; PATHOLOGIST; POTENTIOMETRY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REVIEW; STREPTOLYSIN TITER; THYROXINE BLOOD LEVEL; UREA BLOOD LEVEL; BLOOD; CLINICAL CHEMISTRY; DIAGNOSTIC ERROR; METHODOLOGY; PATHOLOGY; STANDARD;

ARTIFACTS; CLINICAL CHEMISTRY TESTS; DIAGNOSTIC ERRORS; HEMATOLOGIC DISEASES; HUMANS; PATHOLOGY, CLINICAL;

EID: 58849135418     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCPY9RP5QYTYFWC     Document Type: Review

References (89)

1. Brigden ML, Dalal BI. Spurious and artifactual test results, I: cell counter-related abnormalities. Lab Med. 1999;30:326-332.
2. Dalal BI, Brigden ML. Artifacts that may be present on a blood film. Clin Lab Med. 2002;22:81-100.
3. Brigden ML, Dalal BI. Spurious and artifactual test results, II: morphologic abnormalities, pseudosyndromes and spurious test results. Lab Med. 1999;30:397-405.
4. Bonini P, Plebani M, Ceriotti F, et al. Errors in laboratory medicine. Clin Chem. 2002;48:691-698.
5. Owsner SM, Costa J, Homer RJ. Clinicians are from Mars and pathologists are from Venus. Arch Pathol Lab Med. 2000;124:1040-1046.
6. John R, Oleesky D, Issa B, et al. Pseudohypercalcaemia in two patients with IgM paraproteinaemia. Ann Clin Biochem. 1997;34:694-696.
7. Kakkar N, Garg G. Inappropriate platelet transfusion in a patient with ethylenediaminetetra-acetic acid (EDTA)-induced pseudothrombocytopenia [published correction appears in Indian J Pathol Microbiol. 2006;49:476]. Indian J Pathol Microbiol. 2006;49:29-31.
8. Lau LG, Chng WJ, Liu TC. Transfusion medicine illustrated: unnecessary transfusions due to pseudothrombocytopenia. Transfusion. 2004;44:801.
9. Kellerman PS, Thornbery JM. Pseudohyperkalemia due to pneumatic tube transport in a leukemia patient. Am J Kidney Dis. 2005;46:746-748.
10. Wenk RE, Yoho S, Bengzan A. Pseudohypoglycemia with monoclonal immunoglobulin M [letter]. Arch Pathol Lab Med. 2005;129:454-455.
11. Kadri N, Douville P, Lachance P. Monoclonal paraprotein may interfere with the Roche direct HDL-C Plus assay [letter]. Clin Chem. 2002;48:964.
12. Yu A, Pira U. False increase in serum C-reactive protein caused by monoclonal IgM-lambda: a case report. Clin Chem Lab Med. 2001;39:983-987.
13. Gulati GL, Hyland LJ, Kocher W, et al. Changes in automated complete blood cell count and differential leukocyte count results induced by storage of blood at room temperature. Arch Pathol Lab Med. 2002;126:336-342.
14. Sinclair D, Briston P, Young R, et al. Seasonal pseudohyperkalaemia. J Clin Pathol. 2003;56:385-388.
15. Pantanowitz L, Horowitz GL, Palakalin JN, et al. Artifactual hyperbilirubinemia due to paraprotein interference. Arch Pathol Lab Med. 2003;127:55-59.
16. Smogorzewska A, Flood JG, Long WH, et al. Paraprotein interference in automated chemistry analyzers. Clin Chem. 2004;50:1691-1693.
17. Murali M, Kratz A, Finberg KE. Case records of the Massachusetts General Hospital: case 40-2006: a 64-year-old man with anemia and a low level of HDL cholesterol. N Engl J Med. 2006;355:2772-2779.
18. Sinclair D, Smith H, Woodhead P. Spurious hyperphosphataemia caused by an IgA paraprotein: a topic revisited. Ann Clin Biochem. 2004;41:119-124.
19. Bowles SA, Tait RC, Jefferson SG, et al. Characteristics of monoclonal immunoglobulins that interfere with serum inorganic phosphate measurement. Ann Clin Biochem. 1994;31:249-254.
20. Mandry JM, Posner MR, Tucci JR, et al. Hyperphosphatemia in multiple myeloma due to a phosphate-binding immunoglobulin. Cancer. 1991;68:1092-1094.
21. McCloskey EV, Galloway J, Morgan MA, et al. Pseudohyperphosphataemia in multiple myeloma. BMJ. 1989;299:1381-1382.
22. Sonnenblick M, Eylath U, Brisk R, et al. Paraprotein interference with colorimetry of phosphate in serum of some patients with multiple myeloma. Clin Chem. 1986;32:1537-1539.
23. Yamada K, Yagihashi A, Ishii S, et al. Interference with nephelometric assay of C-reactive protein and antistreptolysin-O by monoclonal IgM from a myeloma patient. Clin Chem. 1997;43:2435-2437.
24. Cohen AM, Magazanik A, van-der Lijn E, et al. Pseudohyperphosphataemia incidence in an automatic analyzer. Eur J Clin Chem Clin Biochem. 1994;32:559-561.
25. Lacher DA, Nally JV. Falsely elevated values for serum phosphorus in multiple myeloma. Clin Chem. 1986;32:1232.
26. Hawkins RC. Pseudohyperphosphataemia in multiple myeloma. Ann Clin Biochem. 1991;28(pt 3):226-228.
27. McClure D, Lai LC, Cornell C. Pseudohyperphosphataemia in patients with multiple myeloma. J Clin Pathol. 1992;45:731-732.
28. Jarchovsky I, Beitner H, Plavnick L. Spurious hyperphosphatemia in multiple myeloma [in Hebrew]. Harefuah. 1991;121:515-516.
29. Savory DJ, Pearce JC. Paraprotein interference causing pseudohyperphosphataemia: evaluation of an improved methodology. Ann Clin Biochem. 1995;32:498-501.
30. Zaman Z, Sneyers L, Van Orshoven A, et al. Elimination of paraprotein interference in determination of plasma inorganic phosphate by ammonium molybdate method. Clin Chem. 1995;41:609-614.
31. Weisbord SD, Chaudhuri A, Blauth D, et al. Monoclonal gammopathy and spurious hypophosphatemia. Am J Med Sci. 2003;325:98-100.
32. Lyon AW, Baskin LB. Pseudohyponatremia in a myeloma patient: direct electrode potentiometry is a method worth its salt. Lab Med. 2003;5:357-360.
33. Bern M. Clinically significant pseudohyponatremia. Am J Hematol. 2006;81:557-561.
34. Rhys J, Oleesky D, Issa B, et al. Pseudohypercalcaemia in two patients with IgM paraproteinaemia. Ann Clin Biochem. 1997;34(pt 6):694-696.
35. Langman LJ, Allen LC, Romaschin AD. Interference of IgM paraproteins in the Olympus AU8900 uric acid assay. Clin Biochem. 1998;31:517-521.
36. Johnson CM, Hughes KM. Pseudohyperkalemia secondary to postsplenectomy thrombocytosis. Am Surg. 2001;67:168-170.
37. Datta P, Graham GA, Schoen I. Interference by IgG paraproteins in the Jaffe method for creatinine determination. Am J Clin Pathol. 1986;85:463-468.
38. Pierce GF, Garrett NC, Koenig J, et al. Interference by monoclonal proteins in the o-phthalaldehyde method for blood urea nitrogen. Clin Chim Acta. 1986;154:233-236.
39. Smith JD, Nobiletti J, Freed M, et al. Interference with the Astra 8 and Synchron CX3 assays of urea nitrogen in serum by a high-M(r) inhibitor in a patient with multiple myeloma [letter]. Clin Chem. 1992;38:598-599.
40. Alexander NM, Gattra R, Nishimoto M. Myeloma immunoglobulin interferes with serum thyroxine analysis by homogeneous enzyme immunoassay. Clin Chim Acta. 1980;100:301-305.
41. Fukasawa H, Furuya R, Kato A, et al. Pseudohyperkalemia occurring in a patient with chronic renal failure and polycythemia vera without severe leukocytosis or thrombocytosis. Clin Nephrol. 2002;58:451-454.
42. Stankovic AK, Smith S. Elevated serum potassium values: the role of preanalytical variables. Am J Clin Pathol. 2004;121(suppl):S105-S112.
43. Sevastos N, Theodossiades G, Efstathiou S, et al. Pseudohyperkalemia in serum: the phenomenon and its clinical magnitude. J Lab Clin Med. 2006;147:139-144.
44. Rodriguez-Cuartero A, Pérez-Blanco F, Riera M, et al. Spurious serum hyperkalemia in essential thrombocythemia [letter]. Clin Nephrol. 2004;61:229-230.
45. Colussi G. Pseudohyperkalemia in leukemias [letter]. Am J Kidney Dis. 2006;47:373.
46. Smellie WS. Spurious hyperkalaemia. BMJ. 2007;334: 693-695.
47. Thurlow V, Ozevlat H, Jones SA, et al. Establishing a practical blood platelet threshold to avoid reporting spurious potassium results due to thrombocytosis. Ann Clin Biochem. 2005;42:196-199.
48. Deore R, Harte S, Bowers M, et al. Pseudohyperkalaemia and aetiology of thrombocytosis: a six-year retrospective correlation study [abstract]. Br J Haematol. 2007;137(suppl 1):9. Abstract 25.
49. Nijsten MWN, De Smet BJGL, Dofferhoff ASM. Pseudo- hyperkalemia and platelet counts [letter]. N Engl J Med. 1991;325:1107.
50. Michiels JJ. Pseudohyperkalemia and platelet count in thrombocythemia [letter]. Am J Hematol. 1993;42:237-238.
51. Cheng J, Burke MD. Spurious hypokalemia in a case of acute myeloblastic leukemia [letter]. Lab Med. 1993;24:706-707.
52. Ybarra J, Isern J. Leukocytosis-induced artifactual hypoglycemia [letter]. Endocr J. 2003;50:481-482.
53. Hess CE, Nichols AB, Hunt WB, et al. Pseudohypoxemia secondary to leukemia and thrombocytosis. N Engl J Med. 1979;301:361-363.
54. Loke J, Duffy TP. Normal arterial oxygen saturation with the ear oximeter in patients with leukemia and leukocytosis. Cancer. 1984;53:1767-1769.
55. Lele AV, Mirski MA, Stevens RD. Spurious hypoxemia. Crit Care Med. 2005;33:1854-1856.
56. Mizock BA, Franklin C, Lindesmith P, et al. Confirmation of spurious hypoxemia using continuous blood gas analysis in a patient with chronic myelogenous leukemia. Leuk Res. 1995;19:1001-1004.
57. Charan NB, Marks M, Carvalho P. Use of plasma for arterial blood gas analysis in leukemia. Chest. 1994;105:954-955.
58. Schmaier AH. Pseudohypoxemia due to leukemia and thrombocytosis [letter]. N Engl J Med. 1980;302:584.
59. Gorski TF, Ajemian M, Hussain E, et al. Correlation of pseudohypoxemia and leukocytosis in chronic lymphocytic leukemia. South Med J. 1999;92:817-819.
60. Astles JR, Petros WP, Peters WP, et al. Artifactual hypoglycemia associated with hematopoietic cytokines. Arch Pathol Lab Med. 1995;119:713-716.
61. Owens H, Siparsky G, Bajaj L, et al. Correction of factitious hyperkalemia in hemolyzed specimens. Am J Emerg Med. 2005;23:872-875.
62. Kutter D, Thoma J. Hereditary spherocytosis and other hemolytic anomalies distort diabetic control by glycated hemoglobin. Clin Lab. 2006;52:477-481.
63. Baynes KCR, McIntosh C, Feher MD. Artefactually low glycated haemoglobin is a potential pitfall in diabetes management: consider congenital haemolytic anaemias. Practical Diabetes Int. 2001;18:103-106.
64. Diop ME, Bastard JP, Meunier N, et al. Inappropriately low glycated hemoglobin values and hemolysis in HIV-infected patients. AIDS Res Hum Retroviruses. 2006;22:1242-1247.
65. Vogels IM, Van Noorden CJ, Wolf BH, et al. Cytochemical determination of heterozygous glucose-6-phosphate dehydrogenase deficiency in erythrocytes. Br J Haematol. 1986;63:402-405.
66. Coles SE, Ho MM, Chetty MC, et al. A variant of hereditary stomatocytosis with marked pseudohyperkalaemia. Br J Haematol. 1999;104:275-283.
67. Gore DM, Layton M, Sinha AK, et al. Four pedigrees of the cation-leaky hereditary stomatocytosis class presenting with pseudohyperkalaemia; novel profile of temperature dependence of Na+-K+ leak in a xerocytic form. Br J Haematol. 2004;125:521-527.
68. Stewart GW, Turner EJH. The hereditary stomatocytoses and allied disorders: congenital disorders of erythrocyte membrane permeability to Na and K. Baillieres Best Pract Res Clin Haematol. 1999;12:707-727.
69. Delaunay J. The hereditary stomatocytoses: genetic disorders of the red cell membrane permeability to monovalent cations. Semin Hematol. 2004;41:165-172.
70. 1c determination methods in patients with hemoglobinopathies. Diabetes Care. 2000;23:339-344.
71. 1c) by high performance liquid chromatography. J Clin Pathol. 2000;53:854-857.
72. 1c in a patient with type I diabetes. J Clin Pathol. 1997;50:434-435.
73. 1c levels. Intern Med. 1997;36:351-356.
74. 1c value. Intern Med. 1993;32:128-132.
75. O'Brien DA, Flynn CM, Chuk P, et al. Haemoglobin Etobicoke, an incidental finding in an Irish diabetic. Clin Lab Haematol. 2003;25:259-262.
76. 25(A2)Pro→Ala], an electrophoretically silent variant with impaired glycation. Clin Chem. 2003;49:137-143.
77. 1. Diabet Med. 1988;5:497-498.
78. 1c ] because of haemoglobin OSU-Christiansborg. Clin Lab Haematol. 2005;27:334-335.
79. Villanueva CL, Zavala C, Alcayaga MP. False high levels glycosylated hemoglobin in 2 diabetic patients with persistence of fetal hemoglobin. Rev Med Chil. 1995;123:1129-1132.
80. 1c in an automated ion-exchange HPLC method. Clin Chem. 1998;44:1296-1301.
81. Steinberger BA, Ford SM, Coleman TA. Intravenous immunoglobulin therapy in postinfusional hyperproteinemia increased serum viscosity, and pseudohyponatremia. Am J Hematol. 2003;73:97-100.
82. Colls BM. Guillain-Barré syndrome and hyponatremia. Intere Med J. 2003;33:5-9.
83. Reed RG. Interference by an IgM paraprotein in the bromcresol green method for determination of serum albumin Clin Chem. 1987;33:1075-1076.
84. Hamwi A, Födinger M, Sunder-Plassmann G, et al. Disturbed latex immunoassays for C-reactive protein and ferritin in a renal transplant patient due to polyclonal IgM hypergammaglobulinemia. Nephrol Dial Transplant. 1997;12:1229-1233.
85. Linz LJ. Elevation of hemoglobin, MCH, and MCHC by paraprotein: how to recognize and correct the interference. Clin Lab Sci. 1994;7:211-212.
86. Khoo SM, Lee KH, Notley M. Spurious hypoxaemia in a patient with leukaemia and extreme leucocytosis. Singapore Med J. 2003;44:208-210.
87. 1c Diabetes Metab Res Rev. 2001;17:94-98.
88. Bry L, Chen PC, Sacks DB. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem. 2001;47:153-163.
89. Muggia FM, Heineman HO, Farhangi M, et al. Lysozymuria and renal tubular dysfunction in monocytic and myelomonocytic leukemia. Am J Med. 1969;47:351-366.